- Current View of Orphan Drug Usage in Tertiary Hospital and Rare Incurable Disease Hospital
-
Choi KS, Jeong YM, Kim YJ, Kim YH, Gu H, Lee BK, Lee E, Rhie SJ
- KMID: 2358064
- Korean J Clin Pharm.
- 2016 Jun;26(2):121-127.
- doi: 10.0000/kjcp.2016.26.2.121
OBJECTIVE: Until now, there is minimal number of research for overall domestic status of orphan drug use in Korea. The purpose of this study is to identify the list of... -
- CITED
-
- Close
- SHARE
-
- Close
- The Use of Orphan Drugs for Infectious Disease: Current Status and Unmet Needs
-
Kim MJ, Chang HH, Jin S, Park JH, Jung H, Lee HJ, Choi SH, Kim SW
- KMID: 2268924
- Korean J Med.
- 2015 Dec;89(6):675-680.
- doi: 10.3904/kjm.2015.89.6.675
BACKGROUND/AIMS: The aim of this study was to investigate the inconveniences and potential improvements in the use of orphan drugs for the treatment of infectious diseases, as determined by a... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Lenalidomide-induced Drug Eruption Presenting as Pruritus and Erythema Covering the Whole Body
-
Shin JY, Hong KR, Kim JE, Lee SH, Park YL
- KMID: 2446922
- Korean J Dermatol.
- 2019 Mar;57(3):149-151.
Lenalidomide is an immunomodulatory drug used for the treatment of multiple myeloma. Several cases of hematological, gastrointestinal, and cutaneous side effects have been reported for this drug. A 67-year-old patient... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical experience in managing patients with hereditary angioedema in Korea: questionnaire survey and a literature review
-
Lee SY, Kang HR, Jung JW, Jang GC, Lee SY, Ahn Y, Min KU, Korean Academy of Asthma, Allergy and Clinical Immunology Anaphylaxis Work Group
- KMID: 2262396
- Allergy Asthma Respir Dis.
- 2014 Sep;2(4):277-284.
- doi: 10.4168/aard.2014.2.4.277
PURPOSE: Hereditary angioedema is a familial disease which is caused by a genetic deficiency or functional defect of the C1 inhibitor, and it features episodic swelling that can affect any... -
- CITED
-
- Close
- SHARE
-
- Close
- Statin Intolerance: an Overview of the Current Status and Possible Treatment Options
-
Suh S, Jung CH, Hong SJ, Kim JS, Choi SH
- KMID: 2429828
- J Lipid Atheroscler.
- 2018 Dec;7(2):77-87.
- doi: 10.12997/jla.2018.7.2.77
Lowering serum low-density lipoprotein cholesterol (LDL-C) is the mainstay for reduction of risk of cardiovascular disease (CVD), the second most common cause of death in Korea. The 2015 Korean guidelines... -
- CITED
-
- Close
- SHARE
-
- Close
